Side effects are one reason GLP-1 treatment needs clinical follow-up. Do not assume a symptom is harmless because someone online describes the same experience.

This is a general, incomplete overview based on approved semaglutide and tirzepatide prescribing information and FDA safety communications. Your own product instructions and clinician’s advice should guide your care.

The quick read

  • Report persistent or disruptive symptoms.
  • Urgent symptoms need urgent care, not a routine message.
  • Use instructions for your exact product and concentration.

Common does not mean ignore it

Nausea, vomiting, diarrhea, constipation, and other digestive symptoms are described in approved product labels. Tell your clinician if symptoms persist, interfere with eating or drinking, or make ordinary activities difficult. They can assess the cause and decide whether the treatment plan needs to change.

Symptoms that need prompt attention

Severe or persistent abdominal pain, repeated vomiting, inability to keep fluids down, or signs of dehydration warrant prompt medical advice. Sudden serious symptoms, difficulty breathing, swelling of the face or throat, fainting, or another medical emergency call for emergency care. Do not wait for a routine portal message when symptoms are urgent.

Your other medicines can change the picture

The risk of low blood sugar can increase when these medicines are used with insulin or certain other diabetes drugs. Discuss the monitoring plan with the clinicians managing those medicines. Also report relevant eye disease, stomach problems, pancreatic or gallbladder history, and other conditions before treatment.

Compounded injections add measurement questions

FDA has reported dosing errors involving compounded injectable GLP-1 products. If you think you took the wrong amount, contact a healthcare professional or poison control promptly; seek emergency care for severe symptoms. Keep the vial, packaging, and instructions available so the exact concentration and amount can be assessed.

Avoid changing the plan on your own

Do not speed up dose increases, copy someone else’s schedule, or combine GLP-1 products without clinical direction. If you miss a dose or pause treatment, get instructions for your specific medicine. A review site cannot determine the right restart or adjustment for you.

Prepare before you need help

Save the clinician and pharmacy contact details. Know the routine messaging hours, urgent-care pathway, and refill process. Read the appointment checklist and product verification guide before placing an order.

Sources & reading notes

Public materials checked September 19, 2026. Provider pages establish advertised terms, not independent proof of outcomes or service quality. Clinical information is general and is not personal medical advice. No clinician review of this article is claimed.

  1. Wegovy prescribing information
  2. Zepbound prescribing information
  3. FDA: concerns with unapproved GLP-1 drugs

How we research · How commercial placement works